Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Akt3 deficiency in macrophages promotes foam cell formation and atherosclerosis in mice.

Liang Ding | Sudipta Biswas | Richard E Morton | Jonathan D Smith | Nissim Hay | Tatiana V Byzova | Maria Febbraio | Eugene A Podrez
Cell metabolism | 2012

Akt, a serine-threonine protein kinase, exists as three isoforms. The Akt signaling pathway controls multiple cellular functions in the cardiovascular system, and the atheroprotective endothelial cell-dependent role of Akt1 has been recently demonstrated. The role of Akt3 isoform in cardiovascular pathophysiology is not known. We explored the role of Akt3 in atherosclerosis using mice with a genetic ablation of the Akt3 gene. Using hyperlipidemic ApoE(-/-) mice, we demonstrated a macrophage-dependent, atheroprotective role for Akt3. In vitro experiments demonstrated differential subcellular localization of Akt1 and Akt3 in macrophages and showed that Akt3 specifically inhibits macrophage cholesteryl ester accumulation and foam cell formation, a critical early event in atherogenesis. Mechanistically, Akt3 suppresses foam cell formation by reducing lipoprotein uptake and promoting ACAT-1 degradation via the ubiquitin-proteasome pathway. These studies demonstrate the nonredundant atheroprotective role for Akt3 exerted via the previously unknown link between the Akt signaling pathway and cholesterol metabolism.

Pubmed ID: 22632897

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NCRR NIH HHS, United States
    Id: UL1 RR024989
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL071625
  • Agency: NIA NIH HHS, United States
    Id: R01-AG016927
  • Agency: NHLBI NIH HHS, United States
    Id: HL077213
  • Agency: NHLBI NIH HHS, United States
    Id: P01 HL073311
  • Agency: NIA NIH HHS, United States
    Id: R01 AG016927
  • Agency: NHLBI NIH HHS, United States
    Id: HL071625
  • Agency: NHLBI NIH HHS, United States
    Id: 5P01HL073311-06
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL077213
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL098193
  • Agency: NHLBI NIH HHS, United States
    Id: R01-HL098193
  • Agency: NCI NIH HHS, United States
    Id: R01 CA090764

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Scion Image (tool)

RRID:SCR_008673

THIS RESOURCE IS NO LONGER IN SERVICE, documented on July 17, 2013. Commercial software vendor.

View all literature mentions

Adobe Photoshop (tool)

RRID:SCR_014199

Software for image processing, analysis, and editing. The software includes features such as touch capabilities, a customizable toolbar, 2D and 3D image merging, and Cloud access and options.

View all literature mentions